6RB-12340-72480
1 vaccination
1 coded response
4 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 0-4
- ZIP prefix
- 028 / RI
- Registered
- 2022-07-03
- Relationship
- Child or adolescent in my care
- Guardian
- CEJ-68222-83521
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-06-24
Dose 1 — Moderna
-
2022-07-03
Registered in v-safe
-
2022-07-03
Survey response — day 7, dose 1, under 3MedDRA: Injection site rash — Feeling: Good · Site: RednessFree text: Started one week after injection, one inch splotchy rash at injection site. No other symptoms and she is not bothered!MedDRA releases: 2024-11 · check-in free text available
- 2022-07-08
- 2022-09-23
- 2022-12-25
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-06-24 | Moderna | No |
Free text
Release 12 (Under 3) — day 7, dose 1, under 3
Systemic reaction (other): Started one week after injection, one inch splotchy rash at injection site. No other symptoms and she is not bothered!
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Injection site rash | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release